44 Recruiting HER2-negative Breast Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Related Conditions
Top Recruiting HER2-negative Breast Cancer Studies
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
📍 Karmanos Cancer Institute at McLaren Bay Region — Bay City, Michigan
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
📍 National Institute of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔